Single nucleotide polymorphism variants in the IGF2BP2 gene have been associated with the incidence of breast cancer, including triple negative breast cancer (TNBC), with higher IMP2 protein expression consistent with an oncogenic role [98]. Here, IGF2BP2 is linked to triple-negative breast carcinoma.